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Sunday, February 16, 2014 87aexperiments will lead to discover the so-far unknown properties of cell mem-
branes. Using established methods we grew spheroplasts which were stabilized
in a STOP solution. To test the condition of the cytoplasmic membranes, we
then diluted the STOP solution by adding pure water. We found that as the
STOP solution was diluted, the water influx enlarged the spheroplasts. This
seems to indicate that there is a membrane reservoir (perhaps, invaginations
of cell membrane) in the original state of spheroplast. By the aspiration method,
we measured the tension versus membrane area change of spheroplasts stabi-
lized at 15% STOP solution. The tension vs. area change showed a slow expo-
nential region followed by a linear region, similar to pure lipid GUVs. However
the stretch expansion moduli are 5 times smaller than that of pure lipid bilayers.
When maganin or melittin, were introduced into spheroplast suspension, we
found that the surface area was expanded by more than 5% by peptide binding.
These preliminary results indicate the feasibility of using spheroplasts as an
experimental platform for studying the interaction of membrane-active pep-
tides with cell membranes.
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Antimicrobial peptides (AMPs) are key components of the innate immune sys-
tems of many organisms. AMPs function by permeabilizing microbial mem-
branes, giving them an important advantage over conventional antibiotics as
they may elude the selection of drug-resistance. Therefore, there has been
increasing interest in engineering AMPs and improving their bioactivity over
the last three decades. Yet the lack of obvious structure-function relationships
or molecular design principles has obstructed the development of new AMPs.
To circumvent this roadblock, we are developing a high-throughput approach
to select AMPs that are optimized in all of the critical factors simultaneously.
Previously in our lab, we identified a group of broad-spectrum antimicrobial
peptides from a synthetic peptide library. Here, we used one of the broad-
spectrum AMPs, *ARVA (RRGWALRLVLAY), to study the potency, selec-
tivity and mechanism of action of AMPs in the presence of concentrated human
erythrocytes (10t9 cells/ml) which mimics the in vivo milieu. *ARVA, and
other AMPs, lose antimicrobial activity in concentrated erythrocytes. We
developed a method to make direct measurements of peptide binding to cells
which showed that loss of activity is due to weak host cell binding, coupled
with the large mass excess of host cell vs. bacterial cells under physiological
conditions. To identify AMPs with clinically-relevant activity, we are devel-
oping a novel, orthogonal high-throughput screen in which we select simulta-
neously for 1) peptide solubility; 2) lack of host cell lysis; 3) sterilization of a
Gram positive microbe in the presence of concentrated erythrocytes, and 4)
sterilization of a Gram negative microbe in the presence of concentrated eryth-
rocytes. Our results show that rational library design and high-throughput
screening is a promising approach to identify AMPs that have the needed bal-
ance between antimicrobial potency, solubility and target cell selectivity.
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In our study derivatives of a short cationic peptide derived from the human host
defense peptide Lactoferricin (LFcin) were optimized in their activity and
selectivity towards cancer cells. The negatively charged membrane lipid phos-
phatidylserine (PS) serves as a target for these peptides since PS is specifically
exposed by cancer cells (1).
Calorimetric and permeability studies showed that N-acylation and even more
the repeat sequences of derivatives of hLFcin leads to strongly improved inter-
action with the cancer mimic PS, whereas the healthy mimic phosphatidylcho-
line (PC) is only slightly affected by the lipopeptide. Tryptophan fluorescence
of selective peptides revealed peptide penetration only into the PS membrane
interface and circular dichroism showed change of structure by increase of
amount of b-sheets just in the presence of the cancer mimic. We demonstrated
that hLFcin derivatives also exhibit anticancer activity in vitro against several
cancer cell lines, correlating with selective activity against the cancer model
PS. Active and selective peptides induced apoptosis only in cancer cells,
whereas melanocytes and fibroblasts remained unaffected at same concentra-
tions, yielding specificity for cancer cells higher than 100-fold for some pep-
tides. Currently, first in vivo studies are under progress.
The data indicate the need of high affinity to the target PS, a minimum length
and positive net charge, an adequate but moderate hydrophobicity, and capa-bility of adoption of a defined structure exclusively in presence of the target
membrane for high antitumor activity.
Acknowledgment: Austrian Science Foundation FWF (grant no. P20760,
P24608)
(1) Riedl et al. BBA 1808: 2638-2645, 2011.
465-Pos Board B220
Structure and Glycan-Binding Properties of the Vibrio Vulnificus Hemo-
lysin B-Trefoil Lectin
Katherine Kaus, Rich Olson.
Molecular Biology and Biochemistry, Wesleyan University, Middletown,
CT, USA.
Pore forming toxins (PFTs) are secreted by bacterial pathogens as water-
soluble monomers that oligomerize on the cell surface to form transmembrane
channels. To increase their affinity for the membrane, many PFTs utilize pro-
teins, carbohydrates and/or lipids as receptors. Previous studies suggest that a
PFT secreted by Vibrio cholerae, V. cholerae cytolysin (VCC), recognizes
cell surface glycans in its mode of action. However, while VCC contains two
domains whose structures resemble known carbohydrate binding motifs, a b-
trefoil and b-prism fold, only the b-prism domain actively binds carbohydrate
ligands. This presents the question of why an organism would make a protein
with an inactive lectin domain. Sequence analysis identified that orthologs of
VCC contain either both of the lectin-like domains, or only the b-trefoil
domain. Here, we utilize functional and structural approaches to investigate
the carbohydrate-binding activities of a VCC ortholog, Vibrio vulnificus hemo-
lysin (VVH), which contains only a b-trefoil lectin-like domain. Our studies
identify that the VVH b-trefoil lectin domain binds a broad range of branched
sugars containing multiple N-acetyllactosamine (LacNAc) repeats, with micro-
molar affinity. This is in contrast to the b-prism domain of VCC, which binds a
narrower range of complex N-glycans with nanomolar affinity. We solved the
X-ray crystal structure of the VVH b-trefoil domain identifying two interesting
traits. First, the b-trefoil lectin domain alone forms a heptameric ring character-
istic of many PFTs. Second, VVH contains a unique loop and coordinating res-
idues absent in VCC. We hypothesize an evolutionary relationship between
VVH and VCC such that upon gaining the more specific b-prism domain, ac-
tivity of the b-trefoil domain was lost.
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Brown blotch disease is one of the most serious diseases on many cultivated
mushrooms, such as oyster mushrooms, Agaricus bisporus, and Flammulina ve-
lutipe. The pathogen, identified as Pseudomonas tolaasii, secretes a lipodepsi-
peptide toxin, tolaasin. It is a pore-forming peptide toxin and causes the disease
by making pores on the membranes and disrupting the cellular and fruiting
body structure of mushrooms. Forty-three bacteria were isolated from the culti-
vated mushrooms tissues of the farms reported the outbreaks of brown blotch
disease and identified by the sequence comparison of 16S rRNA genes. Five
different species of Pseudomonas, P1-P5 subgroups, were identified. The P1
group bacteria, including 23 strains, have been identified as the main pathogen
secreting tolaasin peptide. P2-P5 groups are other than P. tolaasii and they also
cause brown blotches in pitting and cultivation tests of oyster mushroom. In the
pitting test using mushroom caps, all five subtypes were able to form brown
blotches. These results suggest that subgroups P2-P5 also secrete tolaasin-
like peptides causing brown blotches. In order to characterize various pore-
forming properties of these peptides, the effects of temperature on the toxicities
of these peptide toxins were measured. The hemolytic activities of toxins from
P1 to P5 subgroups were decreased by increasing temperature from 40 to
100C. The toxicity of toxins was decreased by increasing incubation time
for heat treatment. The tolaasin of P. tolaasii, P1 group, is an 18 amino acid-
peptide, its molecular mass is 1985 Da, and it forms a left-handed a-helix.
Characteristics of the peptide toxins of P2-P5 subgroups are not known. We
have isolated these toxins and compared them with tolaasin by gel permeation
chromatography, ion-exchange column chromatography, HPLC analysis, and
mass spectroscopy.
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Pseudomonas tolaasii causes brown blotch disease on the cultivated mush-
rooms, such as Agaricus bisporus and Pleurotus ostreatu. It secretes a peptide
